| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |